Biotech Shock: Genmab & AbbVie’s Cancer Drug Fails Phase 3 Trial
Автор: Sustainable Pharma
Загружено: 2026-01-17
Просмотров: 18
Описание:
A major setback in biotech.
Genmab and AbbVie’s highly anticipated cancer drug, epcoritamab, has failed its Phase 3 clinical trial after missing its primary endpoint of overall survival in diffuse large B-cell lymphoma.
This wasn’t just another trial. Years of research, billions in investment, and real patient hopes were riding on this outcome.
In this video, we break down what the failure means for patients, clinicians, and investors — and why biotech setbacks, while painful, are an essential part of scientific progress.
The stakes in drug development are massive.
The wins are rare.
But when they happen, they change lives.
Subscribe for clear, no-hype biotech and pharma insights.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
